Home Economy Economic Activity R.I. biotech company secures $1.5M in funding for Alzheimer’s research

R.I. biotech company secures $1.5M in funding for Alzheimer’s research

BOLDEN Therapeutics Inc., a Rhode Island biotech company and Brown University spinoff founded by Dr. Justin Fallon, pictured, received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s. / COURTESY BROWN UNIVERSITY
BOLDEN Therapeutics Inc., a Rhode Island biotech company and Brown University spinoff founded by Dr. Justin Fallon, pictured, received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s. / COURTESY BROWN UNIVERSITY

PROVIDENCE – A Rhode Island-based biotech company received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s disease. The financing, led by Resolute Venture Partners, based in Houston, will enable Bolden Therapeutics Inc. to advance its preclinical development of antisense oligonucleotides to promote neurogenesis. The money comes in the form of pre-seed

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber
  • Critical RI business news and analysis updated daily.
  • 1 year of print (26 issues).
  • Unlimited access to all subscriber only content on our website, on any device.
  • Free email alerts.
  • Annual Book of Lists Print Edition.
  • All special issues produced during subscription term.

RELATED ARTICLES

NO COMMENTS

Copyright ©2026 Providence Business News. All Rights Reserved.
Exit mobile version